Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients-Reference-Cited by-同舟云学术

Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients

Published:2017-06-06 Issue:10 Volume:77 Page:1107-1117
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Zhao Ruizhe¹,Sun Feng¹,Bei Xiaoyu¹,Wang Xingjie¹,Zhu Yiping¹,Jiang Chenyi¹,Zhao Fujun¹,Han Bangmin¹,Xia Shujie¹^ORCID

Affiliation:

1. Department of Urology, Shanghai General Hospital; Shanghai Jiao Tong University School of Medicine; Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Urology,Oncology

Reference22 articles.

1. Global cancer statistics;Jemal;CA: Cancer J Clin,2011

2. Gene variants in the angiogenesis pathway and prostate cancer;Amankwah;Carcinogenesis,2012

3. Non-coding RNAs in human disease;Esteller;Nat Rev Genet,2011

4. Long non-coding RNAs and cancer: a new frontier of translational research;Spizzo;Oncogene,2012

5. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer;Liu;BMC Cancer,2013

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of long non-coding RNA in prostate cancer pathogenesis;Clinical Genitourinary Cancer;2024-08

2. Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers;Critical Reviews in Oncology/Hematology;2024-04

3. Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1;Cancer Letters;2024-03

4. The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies;Cancer and Metastasis Reviews;2023-08-08

5. LncFALEC recruits ART5/PARP1 and promotes castration-resistant prostate cancer through enhancing PARP1-meditated self PARylation;Cellular Oncology;2023-03-13